A Chilean cell-based clinical trial in osteoarthritis reveals the superiority of repetitive MSC injections to Hyaluronic Acid treatment

The study, made by the Chilean biotech company Cells for Cells and Universidad de los Andes Clinical Center, was published in STEM CELLS Translational Medicine journal. The work shows that patients with knee osteoarthritis treated with the allogeneic umbilical cord MSC-based therapy branded as CELLISTEM® OA, experienced a significant improvement in pain reduction, increased mobility […]

Strong attendance, new regulation and growing regional interest mark the annual meeting of the Brazilian Association for Cell Therapy (ABTCEL)

A total of 277 attendees, a record number of 128 selected abstracts and 56 national and international speakers were the figures bolstering up the growing interest for cell therapy in the SCA region. ISCT participated in this successful event, in Sao Paulo, through a joint session focusing on clinical applications. The ISCT awards for best […]

Cardiac risk in Chileans How do we help to face this challenge?

At the end of January, the Ministry of Health announced the second delivery of the results of the National Health Survey (ENS). Among other indicators, it reveals that 25.5 percent of the Chilean population is in the category of high cardiovascular risk. The are many factors and, without a doubt, it is an important challenge […]

Mega showed the history of the Chilean fencer Rubén Silva

Rubén Silva opted by cell therapy. Four years ago, he began to suffer sporadic pains in his wrist that were presented in certain activities that required effort, something unexpected and decisive to practice the sport that he is passionate about and which he is one of the best exponents in Latin America, fencing. When the […]